You have 9 free searches left this month | for more free features.

Condition

Leukemia, Myeloid, Acute (2)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Janssen Pharmaceutical K.K. (1)

Janssen Research & Development, LLC (1)

Collaborator

argenx (2)

Intervention

azacitidine (2)

cusatuzumab (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

cusatuzumab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Leukemia, Myeloid, Acute Trial in Japan (Cusatuzumab, Azacitidine)

Completed

Leukemia, Myeloid, Acute

Cusatuzumab
Azacitidine

Fukushima, Japan
+4 more

Aug 8, 2022

Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine, Cusatuzumab)

Active, not recruiting

Leukemia, Myeloid, Acute

Azacitidine
Cusatuzumab

Darlinghurst, Australia
+55 more

Dec 28, 2022